The World Health Organization on Monday issued a health advisory warning against the use of three ‘poisonous’ cough syrups identified in India. The organization appealed to all the officials that if they come to know about these medicines within their country, then they should immediately inform the health agency about it. WHO said that these medicines can cause serious and fatal diseases, especially for children.
According to WHO, the affected medicines are Coldrif (specific batch) of Srisan Pharmaceuticals, Respifresh TR of Rednex Pharmaceuticals and Relife of Shape Pharma. In these, the quantity of poisonous chemical Diethylene Glycol (DEG) in cough syrup has been found to be many times more than the permissible limit.
The amount of DEG was more than the standard
The amount of DEG in these cough syrups was about 500 times more than the prescribed standards. DEG is an industrial solvent that can cause kidney failure, neurological complications and death.
The agency said the toxic products pose a serious risk and can cause serious, potentially life-threatening illness. These may even result in loss of life.
WHO stressed that India Health Authority CDSCO World Health Organization Told that in Chhindwara, Madhya Pradesh, these cough syrups were allegedly consumed by children below the age of five years, due to which they died.
Poisonous syrup not sent to US
According to WHO, CDSCO clarified that there has been no export of these poisonous drugs from India and there is no evidence of illegal export. The US Food and Drug Administration (FDA) confirmed on Friday that this syrup America Not sent. Nevertheless, WHO has warned about the possibility of export through irregular channels.
At the same time, after the incident, the Indian government took immediate steps and canceled the manufacturing license of Tamil Nadu-based Srisan Pharmaceuticals, which manufactures Coldrif, and arrested the owner of the company. After this the administration sealed the facility in Chennai. Gujarat-based Rednex Pharmaceuticals and Shape Pharma’s Respifresh TR and Relife were withdrawn from sale. Both companies were ordered to stop production of all medicines. The owner of Shape Pharma was also arrested.
—- End —-
